Kenichi Ikejima was graduated from Juntendo University School of Medicine in 1989. He finished PhD course at Juntendo University Graduate School of Medicine in 1996, and studied at University of North Carolina at Chapel Hill as a postdoctoral fellow until 1997. Currently he is Professor of Medicine at Department of Gastroenterology, Juntendo University Graduate School of Medicine since 2017. His expertise covers the whole field of clinical hepatology, and his research topics focus on the pathophysiology of steatotic liver disease (SLD; MASLD, ALD and MetALD). He was the president of APASL-STC 2025 Tokyo, where "the new horizon for SLD" was the main theme. He is currently the governing board member of the International Society for Biomedical Research on Alcoholism (ISBRA) and Asia-Pacific Society for Alcohol and Addiction Research (APSAAR), and the president elect of the International Society for Hepatic Sinusoidal Research (ISHSR).